NatWest Group plc

Position in AMGN — Amgen Inc

CIK 844150 EDINBURGH, SCOTLAND, X0

Position in AMGN

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$11,276,416

-$1,318,757 QoQ

Shares Held

31,140

-13.0% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

2.05%

of 13F equity value

Holder Rank

#514

of 3,140 holders

Holding Since

Sep 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NatWest Group plc holds $63,512,390 across 5 Drug Manufacturers - General names. AMGN ranks #2 (17.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	210,470	$39,909,321
2	AMGN	Amgen Inc This page	31,140	$11,276,416
3	GILD	Gilead Sciences, Inc.	49,485	$6,251,934
4	LLY	ELI LILLY & Co	4,865	$5,835,226
5	JNJ	Johnson & Johnson	943	$239,493

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,276,416	31,140	-13.0%	Shares	Defined	2026-08-10
2026-03-31	$12,595,173	35,797	+88.5%	Shares	Defined	2026-05-11
2023-12-31	$5,468,347	18,986	+123.1%	Shares	Defined	2024-01-12
2023-09-30	$2,287,147	8,510	-0.7%	Shares	Defined	2023-10-12
2023-06-30	$1,902,045	8,567	-1.6%	Shares	Defined	2023-07-25
2023-03-31	$2,105,158	8,708	-44.7%	Shares	Defined	2023-04-24
2022-12-31	$4,136,842	15,751	-1.3%	Shares	Defined	2023-01-27
2022-09-30	$3,596,482	15,956	-13.7%	Shares	Defined	2022-10-31
2022-06-30	$4,498,616	18,490	+9.8%	Shares	Defined	2022-07-20
2022-03-31	$4,072,731	16,842	+28.5%	Shares	Defined	2022-05-03
2021-12-31	$2,949,130	13,109	+23.3%	Shares	Defined	2022-02-07
2021-09-30	$2,260,681	10,631	+85.4%	Shares	Defined	2021-10-26
2021-06-30	$1,397,905	5,735	+0.9%	Shares	Defined	2021-07-21
2021-03-31	$1,414,732	5,686	+1.5%	Shares	Defined	2021-04-16
2020-12-31	$1,288,471	5,604	-10.9%	Shares	Defined	2021-02-04
2020-09-30	$1,599,174	6,292	—	Shares	Defined	2020-11-10
No filing history on record for this holder in this stock.